SIALOR

SIALOR®

SIALOR SIALOR

SIALOR® effectively stimulates saliva flow and is effective for long-term use2,3.

SIALOR® increases salivary secretion to help treat xerostomia through the drug’s action on the secretory cells of the salivary glands.2

Symptoms of chronic dry mouth include4-6:

  • Mouth feels dry or sticky, despite drinking water

  • Difficulty eating, swallowing, or speaking

  • Mouth sores, pain or bad breath

Therapeutic Class:

Dry Mouth

Form:

Tablets

Strength:

25 mg

Format:

60

Ingredients:

Medicinal ingredient: Anetholtrithion.

Non-medicinal ingredients: Anticaking Sucrose, Cochineal Red A, E Wax, Gelatin, Gum Arabic, Guar Gum, Hydrated Colloidal Silica, Lactose, Magnesium Stearate, Sucrose, Sunset Yellow S, Talc, Titanium Dioxide and Wheat Starch.

Indication:

For the treatment of oral symptoms of xerostomia in order to reverse drug-induced hyposialosis related to the administration of certain drugs (neuroleptics, tranquilizers, antidepressants, synthetic antiparkinsonian agents) or following a course of radiotherapy of the head and neck area.

Dosage:

Adults: 3 tablets per day, 1 before each meal. Usually, the full effect of the drug develops gradually over several days of treatment.

Contraindications:

Jaundice, cirrhosis, biliary tract or common bile duct obstruction.

Warnings and precautions:
  • Rare cases of soft stools
  • Should not be used in pregnancy or lactation unless deemed essential to the
welfare of the mother and/or fetus
Storage:

Store between 15°C and 30°C.

Sialor is a registered trademark of BGP Pharma ULC, used under license by Norwell Consumer Healthcare Inc.

These products may not be suitable for everyone. Read the labels and follow the directions of use.

Consult the indications, contraindications, precautions, and dosage and administration at https://pdf.hres.ca/dpd_pm/00036455.PDF for information to help you assess the risks and benefits. This information is also available by contacting us at 1-877-595-2364 or medinfo@norwellcanada.ca.

RAMQ is the official mark of the Régie de l’assurance maladie du Québec.

References:

1. Régie de l’assurance maladie du Québec. List of medications. Available from: https://www.ramq.gouv.qc.ca/sites/default/files/documents/non_indexes/corr-liste_med_2025-09-25_en.pdf. Accessed October 7, 2025.

2. SIALOR® Prescribing Information. Pharmascience Inc. October 31, 2003. Available from: https://pdf.hres.ca/dpd_pm/00036455.PDF.

3. Nagano T, Takeyama M. Enhancement of salivary secretion and neuropeptide (substance P, alpha-calcitonin gene-related peptide) levels in saliva by chronic anethole trithione treatment. Journal of Pharmacy and Pharmacology. 2001;53(12):1697–1702. doi: 10.1211/0022357011778098.

4. Kletas V. Dry Mouth. Canadian Pharmacists Association. November 4, 2020.

5. Pinna R, Campus G, Cumbo E, Mura I, Milia E. Xerostomia induced by radiotherapy: an overview of the physiopathology, clinical evidence, and management of the oral damage. Therapeutics and Clinical Risk Management. 2015;11:171–188. doi: 10.2147/TCRM.S70652.

6. Han P, Suarez-Durall P, Mulligan R. Dry mouth: a critical topic for older adult patients. Journal of Prosthodontic Research. 2015;59(1):6–19. doi: 10.1016/j.jpor.2014.11.001.

This website is intended for educational purposes only and is in no way intended to substitute for professional medical advice, to contradict medical advice given, or to provide medical care of any kind.

To be sure this product is suitable for you, always read and follow the label. As with any medication, speak to your doctor before using.